Robert H. Rosen sold $7.15M worth of shares in Heron Therapeutics, Inc. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011, and HTX-034. The company was founded in February 1983 and is headquartered in Redwood City, CA.